Suppr超能文献

表观遗传激活 AP1 促进鳞状细胞癌转移。

Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.

机构信息

Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA 90095, USA.

出版信息

Sci Signal. 2013 Apr 30;6(273):ra28.1-13, S0-15. doi: 10.1126/scisignal.2003884.

Abstract

The transcription factor AP1 (activating protein 1), a heterodimer of the JUN and FOS proteins, promotes the invasive growth and metastasis of various tumors such as squamous cell carcinoma (SCC), breast cancer, and melanoma. AP1 activity is transcriptionally induced through a positive feedback loop. We identified the histone demethylase KDM4A (lysine-specific demethylase 4A) as a key epigenetic priming factor in this positive feedback loop. KDM4A contributed to the induction of genes encoding the AP1 transcription factors and the invasive growth and metastasis of SCC. KDM4A knockdown decreased the growth factor-induced messenger RNA expression and protein abundance of AP1 family members, including JUN and FOSL1. Mechanistically, histone demethylation by KDM4A facilitated the binding of the AP1 complex to the promoters of JUN and FOSL1, thereby promoting the positive feedback loop that maintains activation of AP1. In a mouse model of SCC, KDM4A knockdown inhibited lymph node metastasis. Moreover, the abundance of KDM4A correlated with the abundance of JUN and FOSL1 in human SCC tissues, and KDM4A expression was increased in human lymph node metastases. Our studies provide insights into the epigenetic control of AP1 and tumor invasion and suggest that KDM4A could be an important therapeutic target for inhibiting invasive SCC growth and metastasis.

摘要

转录因子 AP1(激活蛋白 1)是 JUN 和 FOS 蛋白的异二聚体,促进各种肿瘤的侵袭性生长和转移,如鳞状细胞癌(SCC)、乳腺癌和黑色素瘤。AP1 活性通过正反馈环转录诱导。我们确定组蛋白去甲基化酶 KDM4A(赖氨酸特异性去甲基酶 4A)是该正反馈环中的关键表观遗传启动因子。KDM4A 有助于诱导编码 AP1 转录因子的基因的表达以及 SCC 的侵袭性生长和转移。KDM4A 敲低减少了生长因子诱导的信使 RNA 表达和 AP1 家族成员(包括 JUN 和 FOSL1)的蛋白丰度。从机制上讲,KDM4A 的组蛋白去甲基化促进了 AP1 复合物与 JUN 和 FOSL1 启动子的结合,从而促进了维持 AP1 激活的正反馈环。在 SCC 的小鼠模型中,KDM4A 敲低抑制了淋巴结转移。此外,在人类 SCC 组织中,KDM4A 的丰度与 JUN 和 FOSL1 的丰度相关,并且在人类淋巴结转移中 KDM4A 的表达增加。我们的研究提供了关于 AP1 和肿瘤侵袭的表观遗传控制的见解,并表明 KDM4A 可能是抑制侵袭性 SCC 生长和转移的重要治疗靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fc/3951265/0e6720190c9e/nihms555754f1.jpg

相似文献

引用本文的文献

本文引用的文献

1
Targeting the hepatocyte growth factor-cMET axis in cancer therapy.针对癌症治疗中的肝细胞生长因子-cMET 轴。
J Clin Oncol. 2012 Sep 10;30(26):3287-96. doi: 10.1200/JCO.2011.40.3774. Epub 2012 Aug 6.
4
The molecular biology of head and neck cancer.头颈部癌症的分子生物学。
Nat Rev Cancer. 2011 Jan;11(1):9-22. doi: 10.1038/nrc2982. Epub 2010 Dec 16.
9
Recent advances in head and neck cancer.头颈癌的最新进展
N Engl J Med. 2008 Sep 11;359(11):1143-54. doi: 10.1056/NEJMra0707975.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验